Description
The VISN-12 Veterans Health Administration Network Contracting Office intends to award a Firm Fixed-Price Base plus one year option year contract to Sebia, Inc. 1705 Corporate Dr. STE 400, Norcross, GA 30093 in accordance with Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures. This effort will take place from January 1st, 2024 until December 31st, 2025 with all options. The requirement being sole sourced is for Electrophoresis and Immunofixation reagents, consumable supplies, and preventative maintenance of existing Sebia brand equipment to support mission accomplishment for the VISN-12 VHA Medical Centers (Edward Hines Jr. and Clement J. Zablocki VAMC). The North American Industry Classification System code for this acquisition is 325413 In-Vitro Diagnostic Substance Manufacturing. Size Standard is 1, 250 Employees.This Notice of Intent is not a request for competitive proposals. No solicitation documents are available and telephone requests will not be honored. A competitive acquisition is contemplated to take plave during this period for a new multi-year requirement to fulfill the Government s needs. Any responses to this notice must be sent to the Contracting Officer, Colby Pasholk,
[email protected], in writing via email to the Governments intent. A completed single source Justification and Approval (J&A) will be posted at award.
Active Contract Opportunity Notice ID 36C25224Q0148 Related Notice Department/Ind. Agency VETERANS AFFAIRS, DEPARTMENT OF Sub-tier VETERANS AFFAIRS, DEPARTMENT OF Office 252-NETWORK CONTRACT OFFICE 12 (36C252)
General Information
Contract Opportunity Type: Special Notice (Original)
All Dates/Times are: (UTC-06:00) CENTRAL STANDARD TIME, CHICAGO, USA
Original Published Date: Dec 13, 2023 09:06 am CST
Original Response Date: Dec 15, 2023 02:00 pm CST
Inactive Policy: Manual
Original Inactive Date: Dec 20, 2023
Initiative: None
Classification
Original Set Aside:
Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
NAICS Code: 325413 - In-Vitro Diagnostic Substance Manufacturing
Place of Performance: